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biomechanical mechanisms be relevant to
ankylosing spondylitis and axial spondyloarthritis?
Alfonse T MasiAbstract
Ankylosing spondylitis and axial spondyloarthropathy have characteristic age- and sex-specific onset patterns, typical
entheseal lesions, and marked heritability, but the integrative mechanisms causing the pathophysiological and
structural alterations remain largely undefined. Myofascial tissues are integrated in the body into webs and networks
which permit transmission of passive and active tensional forces that provide stabilizing support and help to control
movements. Axial myofascial hypertonicity was hypothesized as a potential excessive polymorphic trait which could
contribute to chronic biomechanical overloading and exaggerated stresses at entheseal sites. Such a mechanism
may help to integrate many of the characteristic host, pathological, and structural features of ankylosing spondylitis
and axial spondyloarthritis. Biomechanical stress and strain were recently documented to correlate with peripheral
entheseal inflammation and new bone formation in a murine model of spondyloarthritis. Ankylosing spondylitis has
traditionally been classified by the modified New York criteria, which require the presence of definite radiographic
sacroiliac joint lesions. New classification criteria for axial spondyloarthritis now include patients who do not fulfill
the modified New York criteria. The male-to-female sex ratios clearly differed between the two patient categories
- 2:1 or 3:1 in ankylosing spondylitis and 1:1 in non-radiographic axial spondyloarthritis - and this suggests a spectral
concept of disease and, among females, milder structural alterations. Magnetic resonance imaging of active and
chronic lesions in ankylosing spondylitis and axial spondyloarthritis reveals complex patterns, usually interpreted as
inflammatory reactions, but shows similarities to acute degenerative disc disease, which attributed to edema
formation following mechanical stresses and micro-damage. A basic question is whether mechanically induced
microinjury and immunologically mediated inflammatory mechanisms operate in both ankylosing spondylitis and
degenerative disc disease but differ in relative degrees. The hypothesized biomechanical properties raised in this
commentary require documentation of their association with the onset risk and course of ankylosing spondylitis
and axial spondyloarthritis. If particular subsets of ankylosing spondylitis and axial spondyloarthritis patients are
confirmed to have altered axial myofascial properties, their biological basis and underlying biomechanical
mechanisms promise to become clarified. Understanding how biomechanical and physical properties can affect
symptomatic and structural manifestations of these disorders could also improve their management.Correspondence: amasi@uic.edu
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This commentary updates our recent perspectives on in-
tegrated structural aspects of ankylosing spondylitis (AS)
[1,2]. Axial myofascial hypertonicity is hypothesized to
be a potential contributor to entheseal lesions via exag-
gerated attachment stresses [1,2]. Enthesopathy (Greek,
en ‘in’ + thesis ‘a placing’ + pathos ‘suffering’) may be de-
fined as an abnormal process occurring at insertion sites
of muscle, tendons, and ligaments into bones or joint
capsules [3]. These abnormalities often result from
chronic mechanical overloading, with or without evi-
dence of inflammation [3]. The novel hypothesis of a po-
tential intrinsic myofascial mechanism is consistent with
current enthesopathy concepts [1-3]. Recently, a murine
model of spondyloarthritis (SpA) demonstrated that bio-
mechanical stress and strain correlated with entheseal
inflammation and new bone formation [4].
Myofascial tissues are integrated in the body into webs
and networks, which permit transmission of passive and
active tensional forces that provide stabilizing support
and help to control movements. Passive or resting myo-
fascial tension is the innate property, independent of
central nervous system activation, which provides low-
level stabilization to help maintain balanced postures
[2]. Passive axial myofascial tension or tone is proposed
to differ as a polymorphic trait among individuals in the
population of varying age, sex, and possibly heredity,
with minority subsets having counter-opposing outlier
degrees of hypotonicity versus hypertonicity. Accord-
ingly, axial myofascial hypertonicity was hypothesized to
occur in a minority of individuals, which may predispose
them to risk of AS [2].
Pathophysiology of ankylosing spondylitis
Heritability of AS is greater than 90%, and numerous
genetic markers have been identified in genome-wide as-
sociation studies, but the pathophysiology remains
poorly understood [5]. Chronic inflammation is present
in the spinal fibrocartilaginous entheseal lesions of AS
[3]. Synovitis and erosions also occur in the earlier
stages of sacroiliac joint (SIJ) involvement and later
evolve into the characteristic chondral fusion and bony
ankylosis lesions [2,6]. Although mechanical stresses
have been implicated in inflammation at entheseal sites
[3,4] and in initiation of new bone formation or remod-
eling [4,7], the underlying basis for increased stresses
and structural alterations in AS has not been defined.
A hypothesis of innate axial myofascial hypertonicity
was derived as a possible contributor to increased bio-
mechanical predisposition in AS [1,2,8]. The concept is
consistent with the characteristic age- and sex-specific
onset risk patterns of AS. The increased AS onsets dur-
ing adolescent maturation of juveniles and in younger
adulthood as well as in males versus females may reflectgreater axial myofascial strengthening and stiffening in
those respective subgroups [2]. The myofascial hyper-
tonicity hypothesis also integrates form and force ana-
tomical mechanisms, which can biomechanically link the
characteristic spinal and SIJ lesions observed in AS
[2,8,9]. For example, a stiffer axial myofascial system
could chronically exaggerate tensional stresses and
forces transmitted along the spine and might predispose
patients to entheseal micro-damage and syndesmophyte
formation [2,3]. Chronic spinal overloading could also
predispose patients to enhanced SIJ micro-damage and
repair pathways, leading to synovitis, erosions, and the
later stages of enchondral ankylosis [2,6,8,9].
Anti-tumor necrosis factor inhibitor therapy and
structural progression in ankylosing spondylitis
The role of anti-tumor necrosis factor-blocking (anti-
TNF-blocking) agents in modifying the inflammatory
manifestations and new syndesmophyte formation in AS
is incompletely understood [10-12]. Radiographic pro-
gression, as indicated by the modified Stokes AS Spinal
Score (mSASSS), was analyzed in 22 patients with AS
treated with infliximab over an 8-year follow-up as com-
pared with 34 historical control AS patients who had
never been treated with TNF blockers [10]. Although the
mean (standard error of the mean) number of syndes-
mophytes was similar at baseline in the anti-TNF (3.6 ±
5.8) and the historical control (3.7 ± 1.0) patients, the
rate of new syndesmophyte formation per patient over
the 8 years was less (P = 0.007) in the infliximab (1.0 ±
0.6) versus historical control (2.7 ± 0.8) patients [10].
A more recent and larger observational study com-
pared AS patients who had TNF-α inhibitor treatment
with contemporaneous AS patients who had not been
exposed (biologics-naïve) [11]. A reduced rate of interval
radiographic progression (delta mSASSS) was found in
the TNF group, but only for the treatment duration of
4 years or longer (relative rate 0.42, 95% confidence
interval 0.18 to 0.98, P = 0.04). A protective effect of
anti-TNF inhibitor therapy on new bone formation in
AS is difficult to interpret because of complexities of the
observational study designs [10,11]. However, the data
suggest that anti-TNF agents do not accelerate its struc-
tural progression [12]. Further assessment of inflamma-
tory and biomechanical influences on the clinical and
structural progression of AS and axial SpA is needed
[12,13].
Host relations to the onset and course of
ankylosing spondylitis
Historically, AS has been classified by the modified New
York criteria which require the presence of definite
radiographic SIJ lesions [14]. More recently, the Assess-
ment of SpondyloArthritis international Society had
Masi Arthritis Research & Therapy Page 3 of 42014, 16:107
http://arthritis-research.com/content/16/2/107developed classification criteria for axial spondyloarthri-
tis (axSpA) [15], which include patients with non-
radiographic (undifferentiated) axSpA (nr-axSpA) who
do not fulfill the modified New York criteria [14].
More accurate differentiation of patients satisfying the
respective AS [14] and nr-axSpA [15] classification cri-
teria promises to enhance earlier diagnosis, treatment
trials, and improved prediction of outcomes [14-17]. For
example, the male-to-female sex ratios clearly differed
between the two patient categories: 2:1 or 3:1 in AS and
1:1 in nr-axSpA [16,17]. A milder form of AS severity,
observed predominantly in females, had previously been
proposed for HLA-B27-positive relatives of AS probands
who had characteristic symptoms but not radiographic
evidence of SIJ or spine abnormalities [18]. A spectral
concept of AS [15-18] would also warrant further studies
of biomechanical influences affecting host predisposition
to AS vis-a-vis nr-axSpA.
Magnetic resonance imaging of active and
chronic lesions in ankylosing spondylitis and axial
spondyloarthritis
Mechanisms causing signal changes in magnetic reson-
ance imaging (MRI) images of the spine and SIJs are
complex and interpretation has varied [10,17,19,20]. In
degenerative disk disease (DDD), acute or Modic type 1
changes (increased T2-weighted and decreased T1-
weighted images) of vertebral endplate bone and marrow
are believed to represent edema from vascularized fi-
brous tissue resulting from mechanical stresses and
micro-damage [19]. In AS and axSpA, similar acute MRI
signal abnormalities localized characteristically at enthe-
seal vertebral edges (VEs) are interpreted as inflamma-
tory lesions [10,17,20]. Modic type 1 lesions in both
DDD and AS are associated with pain as well as inflam-
matory mediators found localized to such acute MRI
changes [17,19].
The later-stage Modic type 2 MRI changes (increased
T1-weighted and iso- to hyper-intense T2-weighted im-
ages) reflect fatty degeneration of the bone marrow, as is
observed in both DDD [19] and AS [20]. The latest-
stage Modic type 3 change (decreased T1- and T2-
weighted images) is also observed in both diseases and is
attributed to radiographically demonstrated sclerosis and
bone formation of osteophytes in DDD [19] and syndes-
mophytes in AS [20]. A basic question is whether mech-
anically induced microinjury and immunologically
mediated inflammatory mechanisms operate in both AS
and DDD but to different relative degrees.
The relation of sequential type 1 to type 3 changes to
the frequency of new syndesmophyte formation at VEs
was investigated in 73 patients with AS treated with
TNF-blocking agents [20]. If the baseline inflammatory
(type 1) changes resolved during therapy, no newsyndesmophyte formation was observed in follow-up
[20]. In contrast, if baseline fatty degeneration (type 2)
lesions remained unchanged under anti-TNF therapy at
2 years, then the relative risk for new syndesmophyte
formation from baseline to 2 years was 5.0 (P = 0.002)
and to 5 years was 3.3 (P = 0.009) [20]. The underlying
bases of early and sequential MRI changes in AS and
axSpA deserve further definition and differentiation.
If the novel biomechanical properties raised in this
commentary are documented to associate with predis-
position or course of AS and axSpA, then their under-
lying mechanisms could help to clarify the biological
basis, classification, and management of these disorders
and to improve understanding of how physical modal-
ities can affect symptomatic and functional measures.
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